Johnson & Johnson (JNJ)
144.47
+0.89
(+0.62%)
USD |
NYSE |
Dec 20, 16:00
144.61
+0.14
(+0.10%)
After-Hours: 20:00
Johnson & Johnson Cash from Investing (Quarterly): -3.128B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
| AbbVie Inc | -8.256B |
| Bristol-Myers Squibb Co | -219.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.993B |
| Cash from Financing (Quarterly) | -9.882B |
| Free Cash Flow | 19.02B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 11.45B |
| Free Cash Flow to Firm (Quarterly) | 5.714B |
| Free Cash Flow Yield | 5.42% |